"But Ozempic is the one that a lot of people do use." Ozempic along with other glp-1s provide users with a filling sensation that makes users think that they are full longer and reduces their overall calorie intake
Urva et al., The novel GIP, GLP- 1 and glucagon receptor agonist retatrutide delays gastric emptying, Diabetes Obes
Prabhakaran S, Ruff I, Bernstein RA
Ian Neeland, MD So I think it is first line in certain situations and certain patient contexts, lifestyle is always the cornerstone of weight loss therapy, right
Given the accumulating evidence from biomarkers, metabolic disturbances, and neuroimaging, future research should focus on integrating multimodal approaches to establish robust diagnostic tools for ME/CFS